Frequency of the minor BCR-ABL (e1;a2) transcript oncogene in a Mexican population with adult acute lymphoblastic leukaemia
Background: The minor BCR-ABL (e1;a2) transcript oncogene is the most common genetic alteration in adults with acute lymphoblastic leukaemia (ALL). It is associated with a poor prognosis. Aim: To determine the frequency of minor BCR-ABL (e1;a2) transcript oncogene expression in ALL patients in Mexic...
Main Authors: | I. Olarte-Carrillo, C.O. Ramos-Peñafiel, E. Miranda-Peralta, I. Mendoza-Salas, K.A. Nacho-Vargas, J.A. Zamora-Domínguez, E. Mendoza-García, E. Rozen-Fuller, J.J. Kassack-Ipiña, J. Collazo-Jaloma, A. Martínez-Tovar |
---|---|
Format: | Article |
Language: | English |
Published: |
Permanyer
2015-07-01
|
Series: | Revista Médica del Hospital General de México |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0185106315000438 |
Similar Items
-
Targeting BCR-ABL1-positive leukaemias: a review article
by: Steven Leak, et al.
Published: (2023-01-01) -
Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I
by: Mian Afsar, et al.
Published: (2012-09-01) -
Overcoming Bcr-Abl T315I mutation by combination of GNF-2 and ATP competitors in an Abl-independent mechanism
by: Khateb Mamduh, et al.
Published: (2012-11-01) -
Computational Identification of BCR-ABL Oncogenic Signaling as a Candidate Target of Withaferin A and Withanone
by: Vidhi Malik, et al.
Published: (2022-01-01) -
Successful treatment with ABL tyrosine kinase inhibitor for patients with acute myeloid leukemia with BCR-ABL1
by: Asako Takeuchi, et al.
Published: (2021-01-01)